Mark Sean Taylor
Founder
"In a bid to reduce the inevitable following an early-stage pancreatic cancer diagnosis, I decided to concentrate my life mission on helping patients establish effective solutions for cancer."
The initiative is led by Mark Sean Taylor, who spent 20 years working in finance and technology across London, New York, Hong Kong, Istanbul and São Paulo. In 2016 he was diagnosed with minimal residual disease pancreatic cancer through circulating tumour cells.
He was rejected for standard-of-care medicine, as the level of cancer was below what mainstream medicine recognises for a formal diagnosis. This forced him into integrative medicine as an initial skeptic. He has since spent over $500,000 USD on treatments and tests at some of the top medical institutions around the world, learning the approaches of some of the world's leading integrative doctors.
After starting the Patient Led Oncology Trials Facebook group, tracking the progress of hundreds of cancer patients following almost every well-known integrative treatment, he has identified effective approaches that work well, supported by data, patient reports and research. He is an avid cancer researcher who now works with and advises some of the top integrative cancer clinics around the world.
Gabriele Gavazzi
Researcher & Author
"Within the next 5 to 10 years, cancer will become as manageable as diabetes is today."
Gabriele's story is one of resilience, intellectual curiosity, and a deep personal connection to the fight against cancer. Armed with a Master's in Mathematical Finance and a passion for science, particularly biology, he ventured into the entrepreneurial world, establishing a company specializing in dermatology and medical device furnishings.
His move to become a cancer researcher and volunteer for Patient Led Oncology Trials was inspired not just by a love for science, but by a profound personal history with cancer affecting many family members. The turning point came three years ago when his grandmother, aged 85, was diagnosed with Stage 2 colorectal cancer. After a successful yet taxing surgery, a 5 cm lesion emerged on her neck; the metastasis diagnosis came as a shock, with the oncologist predicting two months at most. Recognizing the impact of the nocebo effect on prognosis and morale, Gabriele took it upon himself to soften the translation of the diagnosis, beginning an intensive research journey.
Diving deep into over 3,000 studies, with a focus on off-label use, immunotherapy and autologous cell therapies, Gabriele developed three innovative rainbow protocols, which he later shared with the world. His grandmother, after an off-label regimen of IV polyphenols, IV vitamin C and cryoablation of the mass, passed away peacefully from natural causes more than two years later, spared the constant dread of impending death that following her oncologist's prognosis blindly would have brought.
Meeting Mark and his group inspired him further. He recognized a significant gap in the healthcare system: the need for a bridge between the intricate world of medical research and the practical, everyday needs of patients, leading him to author a book that demystifies cancer treatment and research, presenting complex information in an accessible way. His story is one of hope, empowerment, and the conviction that individuals can indeed influence their health outcomes.
